| pubmed-article:17437845 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:17437845 | lifeskim:mentions | umls-concept:C0001483 | lld:lifeskim |
| pubmed-article:17437845 | lifeskim:mentions | umls-concept:C0017296 | lld:lifeskim |
| pubmed-article:17437845 | lifeskim:mentions | umls-concept:C1336527 | lld:lifeskim |
| pubmed-article:17437845 | lifeskim:mentions | umls-concept:C0078058 | lld:lifeskim |
| pubmed-article:17437845 | lifeskim:mentions | umls-concept:C0002199 | lld:lifeskim |
| pubmed-article:17437845 | lifeskim:mentions | umls-concept:C1280500 | lld:lifeskim |
| pubmed-article:17437845 | lifeskim:mentions | umls-concept:C1171892 | lld:lifeskim |
| pubmed-article:17437845 | lifeskim:mentions | umls-concept:C0127400 | lld:lifeskim |
| pubmed-article:17437845 | pubmed:issue | 5 | lld:pubmed |
| pubmed-article:17437845 | pubmed:dateCreated | 2007-4-17 | lld:pubmed |
| pubmed-article:17437845 | pubmed:abstractText | Intravesical adenovirus mediated interferon-alpha gene transfer has a potent therapeutic effect against superficial human bladder carcinoma xenografts growing in the bladder of athymic nude mice. We determined whether the inhibition of angiogenesis might contribute to the antitumor effect. | lld:pubmed |
| pubmed-article:17437845 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17437845 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17437845 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17437845 | pubmed:language | eng | lld:pubmed |
| pubmed-article:17437845 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17437845 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:17437845 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17437845 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17437845 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17437845 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17437845 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17437845 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17437845 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17437845 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17437845 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17437845 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17437845 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17437845 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:17437845 | pubmed:month | May | lld:pubmed |
| pubmed-article:17437845 | pubmed:issn | 0022-5347 | lld:pubmed |
| pubmed-article:17437845 | pubmed:author | pubmed-author:AdamLianaL | lld:pubmed |
| pubmed-article:17437845 | pubmed:author | pubmed-author:BenedictWilli... | lld:pubmed |
| pubmed-article:17437845 | pubmed:author | pubmed-author:DinneyColin... | lld:pubmed |
| pubmed-article:17437845 | pubmed:author | pubmed-author:KassoufWassim... | lld:pubmed |
| pubmed-article:17437845 | pubmed:author | pubmed-author:MunsellMark... | lld:pubmed |
| pubmed-article:17437845 | pubmed:author | pubmed-author:McConkeyDavid... | lld:pubmed |
| pubmed-article:17437845 | pubmed:author | pubmed-author:BlackPeter... | lld:pubmed |
| pubmed-article:17437845 | pubmed:author | pubmed-author:EveBerylB | lld:pubmed |
| pubmed-article:17437845 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:17437845 | pubmed:volume | 177 | lld:pubmed |
| pubmed-article:17437845 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:17437845 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:17437845 | pubmed:pagination | 1900-6 | lld:pubmed |
| pubmed-article:17437845 | pubmed:dateRevised | 2011-11-17 | lld:pubmed |
| pubmed-article:17437845 | pubmed:meshHeading | pubmed-meshheading:17437845... | lld:pubmed |
| pubmed-article:17437845 | pubmed:meshHeading | pubmed-meshheading:17437845... | lld:pubmed |
| pubmed-article:17437845 | pubmed:meshHeading | pubmed-meshheading:17437845... | lld:pubmed |
| pubmed-article:17437845 | pubmed:meshHeading | pubmed-meshheading:17437845... | lld:pubmed |
| pubmed-article:17437845 | pubmed:meshHeading | pubmed-meshheading:17437845... | lld:pubmed |
| pubmed-article:17437845 | pubmed:meshHeading | pubmed-meshheading:17437845... | lld:pubmed |
| pubmed-article:17437845 | pubmed:meshHeading | pubmed-meshheading:17437845... | lld:pubmed |
| pubmed-article:17437845 | pubmed:meshHeading | pubmed-meshheading:17437845... | lld:pubmed |
| pubmed-article:17437845 | pubmed:meshHeading | pubmed-meshheading:17437845... | lld:pubmed |
| pubmed-article:17437845 | pubmed:meshHeading | pubmed-meshheading:17437845... | lld:pubmed |
| pubmed-article:17437845 | pubmed:meshHeading | pubmed-meshheading:17437845... | lld:pubmed |
| pubmed-article:17437845 | pubmed:meshHeading | pubmed-meshheading:17437845... | lld:pubmed |
| pubmed-article:17437845 | pubmed:meshHeading | pubmed-meshheading:17437845... | lld:pubmed |
| pubmed-article:17437845 | pubmed:meshHeading | pubmed-meshheading:17437845... | lld:pubmed |
| pubmed-article:17437845 | pubmed:meshHeading | pubmed-meshheading:17437845... | lld:pubmed |
| pubmed-article:17437845 | pubmed:meshHeading | pubmed-meshheading:17437845... | lld:pubmed |
| pubmed-article:17437845 | pubmed:meshHeading | pubmed-meshheading:17437845... | lld:pubmed |
| pubmed-article:17437845 | pubmed:meshHeading | pubmed-meshheading:17437845... | lld:pubmed |
| pubmed-article:17437845 | pubmed:meshHeading | pubmed-meshheading:17437845... | lld:pubmed |
| pubmed-article:17437845 | pubmed:meshHeading | pubmed-meshheading:17437845... | lld:pubmed |
| pubmed-article:17437845 | pubmed:meshHeading | pubmed-meshheading:17437845... | lld:pubmed |
| pubmed-article:17437845 | pubmed:meshHeading | pubmed-meshheading:17437845... | lld:pubmed |
| pubmed-article:17437845 | pubmed:meshHeading | pubmed-meshheading:17437845... | lld:pubmed |
| pubmed-article:17437845 | pubmed:meshHeading | pubmed-meshheading:17437845... | lld:pubmed |
| pubmed-article:17437845 | pubmed:year | 2007 | lld:pubmed |
| pubmed-article:17437845 | pubmed:articleTitle | Adenoviral mediated interferon-alpha 2b gene therapy suppresses the pro-angiogenic effect of vascular endothelial growth factor in superficial bladder cancer. | lld:pubmed |
| pubmed-article:17437845 | pubmed:affiliation | Department of Urology, University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA. ladam@mdanderson.org | lld:pubmed |
| pubmed-article:17437845 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:17437845 | pubmed:publicationType | Research Support, N.I.H., Extramural | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17437845 | lld:pubmed |
